# PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age)

> **NCT03709914** · PHASE1 · UNKNOWN · sponsor: **Nabriva Therapeutics AG** · enrollment: 21 (estimated)

## Conditions studied

- Pediatric ALL

## Interventions

- **DRUG:** ZTI-01 100 mg/kg
- **DRUG:** ZTI-01 75 mg/kg

## Key facts

- **NCT ID:** NCT03709914
- **Lead sponsor:** Nabriva Therapeutics AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-24
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-01-10
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2023-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03709914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03709914, "PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03709914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*